To further predict the role of S100A9 in AKI, we monitored the reduction in renal function following renal UIRI and the effects of the human recombinant S100A9 protein administration with twice, high‐dose, S.C. and I.V. injection. This evidence concerns the gene S100A9 and acute kidney injury.